Cell Impact AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 27.5 million compared to SEK 8.5 million a year ago. Net loss was SEK 14.7 million compared to SEK 6.1 million a year ago. Basic loss per share from continuing operations was SEK 0.25 compared to SEK 0.12 a year ago. For the nine months, sales was SEK 60.8 million compared to SEK 20.4 million a year ago. Net loss was SEK 53.2 million compared to SEK 31.5 million a year ago. Basic loss per share from continuing operations was SEK 0.9 compared to SEK 0.66 a year ago.